SecBot SecBot
SECBOTREPLAY Home › Report › CC

CC · Chemours filed an 8-K furnishing its September 2026 investor…

Chemours Co · 8-K filed Sep 9, 2026 at 06:31 ET

At the news

NEUTRALIMPACT 3/10

8-K filed Sep 9, 2026 at 06:31 ET

Chemours filed an 8-K furnishing its September 2026 investor presentation, which recaps Q2 2026 results, the Pathway to Thrive strategy, and growth initiatives in AI infrastructure and data center cooling. The presentation reiterates known financial data (Net Sales $1,591M, Adj. EBITDA $247M) and forward-looking targets (net leverage below 3x, >$250M cost savings), but does not introduce material new information or guidance changes.

  • Q2 2026 Net Sales of $1,591M, down ~1.5% YoY from $1,615M
  • Q2 2026 Adj. EBITDA of $247M, down from $260M YoY
  • Free Cash Flow improved 128% YoY to $114M; FCF conversion 46%
  • Net leverage declined to 4.4x from Q1 2026; targeting below 3x

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access